Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Nutriband Inc WT (NTRBW)

Nutriband Inc WT (NTRBW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 2,090 K
  • Annual Income, $ -5,490 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 12/10/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +38.69%
on 12/04/24
2.3900 -20.50%
on 12/02/24
+0.4000 (+26.67%)
since 11/21/24
3-Month
0.7500 +153.33%
on 11/15/24
2.3900 -20.50%
on 12/02/24
+0.6500 (+52.00%)
since 09/23/24
52-Week
0.1885 +907.96%
on 03/13/24
3.4400 -44.77%
on 07/25/24
+1.6224 (+584.44%)
since 12/21/23

Most Recent Stories

More News
Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
Nutriband Inc. to Present at The 2024 Noble Conference in Boca Raton on December 4th

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
Nutriband Inc. Announces Patent Grant for AVERSAâ„¢ Abuse Deterrent Transdermal Technology in Hong Kong

Nutriband receives Hong Kong patent for AVERSAâ„¢ abuse-deterrent transdermal technology, enhancing opioid safety and accessibility.Quiver AI SummaryNutriband Inc. announced that it has received a Notice...

NTRBW : 1.9000 (+21.79%)
Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversaâ„¢ Abuse Deterrent Transdermal Technology

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

EQNX::TICKER_START (NASDAQ:NTRB),(NASDAQ:NTRBW),(NYSE:TEVA),(NYSE:LLY),(NYSE:NVS),(NASDAQ:AMRX) EQNX::TICKER_END

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
LLY : 795.67 (-0.08%)
NVS : 98.35 (-0.10%)
TEVA : 22.42 (+0.95%)
AMRX : 7.85 (+0.77%)
As Fentanyl Crisis Escalates, Abuse-Deterrent Formulations to Zero in on the Rising Epidemic of Opiate Abuse

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
LLY : 795.67 (-0.08%)
NVS : 98.35 (-0.10%)
TEVA : 22.42 (+0.95%)
AMRX : 7.85 (+0.77%)
NUTRIBAND RECEIVES CHINA PATENT NOTICE OF ALLOWANCE FOR ITS AVERSAâ„¢ ABUSE DETERRENT TRANSDERMAL TECHNOLOGY

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for a patent application covering its Nutriband AVERSA™ abuse deterrent transdermal technology   Nutriband...

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
Nutriband (NASDAQ: NTRB) Engages IBN for Corporate Communications Expertise

Nutriband (NASDAQ: NTRB, NTRBW), a pharmaceutical company with a special focus on transdermal technologies, today announced that it has selected IBN , a multifaceted financial news and publishing company...

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
Nutriband (NASDAQ: NTRB) Closes $8.4M Private Placement

Nutriband (NASDAQ: NTRB, NTRBW), a company engaged in the development of prescription transdermal pharmaceutical products, today announced that it has closed an $8.4 million private placement to fund the...

NTRB : 3.89 (-2.24%)
NTRBW : 1.9000 (+21.79%)
Demand for Abuse Deterrent Formulation Technology Skyrocketing as Opiate Abuse is on the Rise

/PRNewswire/ -- The demand for abuse deterrent formulation technology is projected to grow due to growing misuse of drugs among the people. Growing demand for...

NTRBW : 1.9000 (+21.79%)
CYBN : 9.53 (-0.10%)
NTRB : 3.89 (-2.24%)
CMND : 1.7200 (+40.98%)
MNMD : 7.32 (+3.39%)
LLY : 795.67 (-0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar